Skip to main content

Want a detailed portfolio tracker?

Performance analysis of AN2 Therapeutics (ANTX)

Annual Return

Over the past 3 years, ANTX has had an average annual return of -15.01%, underperforming the benchmark SPY, which returned +19.31% annual.

Since Mar 25, 2022, ANTX has had an average annual return of -23.63%, underperforming the benchmark SPY, which returned +13.62% annual.

20262025202420232022
+321.22%-17.41%-93.27%+115.01%-38.12%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-0.81%-2.72%+211.06%+33.05%-4.84%+11.77%-0.83%+321.22%
2025-17.41%+0%+19.32%-8.83%-14.53%+0%+0%+3.78%+15.55%-3.15%-11.39%+4.52%-17.41%
2024-5.81%-84.56%+9.04%-26.16%-17.07%+8.05%+18.62%-55.68%-5.31%+0.86%+54.64%-17.34%-93.27%
2023+27.60%-7.23%-12.51%-20.47%-28.53%+51.50%-4.46%+85.21%+6.92%-10.32%+21.84%+16.62%+115.01%
2022-2.14%+3.71%-4.03%-48.34%+10.45%+100.25%+1.40%-17.03%-30.86%-4.42%-38.12%

Drawdown analysis of AN2 Therapeutics (ANTX)

The maximum drawdown for the ANTX was -95.61%, occurring on Aug 16, 2024. This drawdown has not yet recovered.

The current ANTX drawdown is -78.46%.

Since Mar 25, 2022 ANTX has experienced the following drawdowns:

  • 50% or more: 2 times
  • 40% or more: 2 times
  • 30% or more: 2 times
  • 20% or more: 2 times
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-95.61%Aug 15, 2022504Aug 16, 2024OngoingOngoingOngoing
-59.56%May 6, 202258Aug 1, 20229Aug 12, 202267
-13.49%Apr 1, 20226Apr 11, 202212Apr 28, 202218
-2.60%Mar 25, 20223Mar 30, 20222Apr 1, 20225
-1.83%Apr 28, 20221Apr 29, 20221May 2, 20222
-1.31%May 2, 20221May 3, 20221May 4, 20222